Diabetes Research Today is a free monthly online journal that collates and summarizes the latest research about Diabetes, including details on insulin, type i, type ii, diet, treatment, prevention.

Volume 5 (2008), Issue 8 (August)

1. Risk of stroke, heart attack, and diabetes complications among veterans with spinal cord injury.
   Arch Phys Med Rehabil, 89(8): 1448-53. [Abstract] [Full-text]
2. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema.
   Ophthalmology, 115(8): 1366-71, 1371.e1. [Abstract] [Full-text]
3. Diabetes mellitus medication assistance program: relationship of effectiveness to adherence.
   J Health Care Poor Underserved, 19(3): 677-86. [Abstract] [Full-text]
4. A medical home for children with insulin-dependent diabetes: comanagement by primary and subspecialty physicians--convergence and divergence of opinions.
   Pediatrics, 122(2): e383-7. [Abstract] [Full-text]
5. Disruption of the homeostatic balance between autoaggressive (CD4+CD40+) and regulatory (CD4+CD25+FoxP3+) T cells promotes diabetes.
   J Leukoc Biol, 84(2): 431-9. [Abstract] [Full-text]
6. Maternal serum alpha-fetoprotein values in type 1 and type 2 diabetic patients.
   Am J Obstet Gynecol, 199(2): 135.e1-5. [Abstract] [Full-text]
7. Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.
   Hepatology, 48(2): 432-41. [Abstract] [Full-text]
8. Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes mellitus.
   Am J Cardiol, 102(4): 497-8. [Abstract] [Full-text]
9. Efficacy and safety of a potent and selective peroxisome proliferator activated receptor alpha agonist in subjects with dyslipidemia and type 2 diabetes mellitus.
   Am J Cardiol, 102(4): 434-9. [Abstract] [Full-text]
10. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Am J Cardiol, 102(4): 396-400. [Abstract] [Full-text]
11. Effects of adiponectin on growth and differentiation of human keratinocytes--implication of impaired wound healing in diabetes.
    Biochem Biophys Res Commun, 374(2): 269-73. [Abstract] [Full-text]
12. Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation.
    Biochem Biophys Res Commun, 374(2): 282-7. [Abstract] [Full-text]
13. Evaluation of a diabetes management program in China demonstrated association of improved continuity of care with clinical outcomes.
    J Clin Epidemiol, 61(9): 932-9. [Abstract] [Full-text]
14. Assessing continuity of care in a community diabetes program: initial questionnaire development and validation.
    J Clin Epidemiol, 61(9): 925-31. [Abstract] [Full-text]
15. Birth weight and subsequent risk of childhood primary brain tumors: a meta-analysis.
    Am J Epidemiol, 168(4): 366-73. [Abstract] [Full-text]
16. Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis.
    Am J Epidemiol, 168(4): 358-65. [Abstract] [Full-text]
17. Electronic medical records in diabetes consultations: participants' gaze as an interactional resource.
    Qual Health Res, 18(9): 1247-63. [Abstract] [Full-text]
18. AT1-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats.
    Free Radic Biol Med, 45(5): 619-26. [Abstract] [Full-text]
19. Elevation of apolipoprotein A-I and apolipoprotein H levels in the vitreous fluid and overexpression in the retina of diabetic patients.
    Arch Ophthalmol, 126(8): 1076-81. [Abstract] [Full-text]
20. Improving health behaviors in an African American community: the Charlotte Racial and Ethnic Approaches to Community Health project.
    Am J Public Health, 98(9): 1678-84. [Abstract] [Full-text]
21. Potassium channels sensitive to combination of charybdotoxin and apamin regulate the tone of diabetic isolated canine coronary arteries.
    Acta Physiol (Oxf), 194(1): 35-43. [Abstract] [Full-text]
22. Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice.
    Neurosci Lett, 442(3): 267-72. [Abstract] [Full-text]
23. Weak or no association of TCF7L2 variants with Type 2 diabetes risk in an Arab population.
    BMC Med Genet, 9: 72. [Abstract] [Full-text]
24. Salt consumption-dependent association of the GNB3 gene polymorphism with type 2 DM.
    Biochem Biophys Res Commun, 374(3): 576-80. [Abstract] [Full-text]
25. Serum vitamin D and subsequent occurrence of type 2 diabetes.
    Epidemiology, 19(5): 666-71. [Abstract] [Full-text]
26. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Arch Pharm Res, 31(7): 918-23. [Abstract] [Full-text]
27. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
    J Am Coll Cardiol, 52(8): 655-66. [Abstract] [Full-text]
28. Determinants of postprandial triglyceride and glucose responses after two consecutive fat-rich or carbohydrate-rich meals in normoglycemic women and in women with type 2 diabetes mellitus: the Hoorn Prandial Study.
    Metabolism, 57(9): 1262-9. [Abstract] [Full-text]
29. Oxidative stress in Cohen diabetic rat model by high-sucrose, low-copper diet: inducing pancreatic damage and diabetes.
    Metabolism, 57(9): 1253-61. [Abstract] [Full-text]
30. Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus.
    Metabolism, 57(9): 1248-52. [Abstract] [Full-text]
31. TCF7L2 gene expression in human visceral and subcutaneous adipose tissue is differentially regulated but not associated with type 2 diabetes mellitus.
    Metabolism, 57(9): 1227-31. [Abstract] [Full-text]
32. Co-associations between insulin sensitivity and measures of liver function, subclinical inflammation, and hematology.
    Metabolism, 57(9): 1190-7. [Abstract] [Full-text]
33. Endothelial dysfunction and serum fatty acid composition in patients with type 2 diabetes mellitus.
    Metabolism, 57(9): 1167-72. [Abstract] [Full-text]
34. One amino acid difference is critical for suppression of the development of experimental autoimmune diabetes (EAD) with intravenous injection of insulinB:9-23 peptide.
    Biochem Biophys Res Commun, 374(3): 581-6. [Abstract] [Full-text]
35. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.
    Lancet, 372(9638): 547-53. [Abstract] [Full-text]
36. Effects of high-fat diet exposure during fetal life on type 2 diabetes development in the progeny.
    J Lipid Res, 49(9): 1936-45. [Abstract] [Full-text]
37. Significance of phlebosclerosis in non-healing ischaemic foot ulcers of end-stage renal disease.
    Eur J Vasc Endovasc Surg, 36(3): 346-52. [Abstract] [Full-text]
38. Angioplasty for diabetic patients with failing bypass graft or residual critical ischemia after bypass graft.
    Eur J Vasc Endovasc Surg, 36(3): 331-8. [Abstract] [Full-text]
39. Streptozocin-induced diabetic mouse model of urinary tract infection.
    Infect Immun, 76(9): 4290-8. [Abstract] [Full-text]
40. Arsenic exposure and prevalence of type 2 diabetes in US adults.
    JAMA, 300(7): 814-22. [Abstract] [Full-text]
41. Blunted excitability of aortic baroreceptor neurons in diabetic rats: involvement of hyperpolarization-activated channel.
    Cardiovasc Res, 79(4): 715-21. [Abstract] [Full-text]
42. Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation.
    Transplantation, 86(3): 478-81. [Abstract] [Full-text]
43. Disruption of Ang-1/Tie-2 signaling contributes to the impaired myocardial vascular maturation and angiogenesis in type II diabetic mice.
    Arterioscler Thromb Vasc Biol, 28(9): 1606-13. [Abstract] [Full-text]
44. Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition.
    Hypertension, 52(3): 573-80. [Abstract] [Full-text]
45. Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective.
    Diabetes Technol Ther, 10(5): 397-403. [Abstract] [Full-text]
46. Pramlintide reduces the risks associated with glucose variability in type 1 diabetes.
    Diabetes Technol Ther, 10(5): 391-6. [Abstract] [Full-text]
47. The accuracy and efficacy of real-time continuous glucose monitoring sensor in patients with type 1 diabetes.
    Diabetes Technol Ther, 10(5): 385-90. [Abstract] [Full-text]
48. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.
    Diabetes Technol Ther, 10(5): 377-83. [Abstract] [Full-text]
49. Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software.
    Diabetes Technol Ther, 10(5): 369-75. [Abstract] [Full-text]
50. Comparison of gliclazide with insulin as initial treatment modality in newly diagnosed type 2 diabetes.
    Diabetes Technol Ther, 10(5): 363-8. [Abstract] [Full-text]
51. Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels.
    Diabetes Technol Ther, 10(5): 359-62. [Abstract] [Full-text]
52. Validation of the SoloSTAR insulin pen.
    Diabetes Technol Ther, 10(5): 351-7. [Abstract] [Full-text]
53. Beyond the era of NPH insulin--long-acting insulin analogs: chemistry, comparative pharmacology, and clinical application.
    Diabetes Technol Ther, 10(5): 333-49. [Abstract] [Full-text]
54. Prevalence of structural central nervous system abnormalities in early-onset type 1 diabetes mellitus.
    J Pediatr, 153(3): 385-90. [Abstract] [Full-text]
55. A randomized comparison of sirolimus- versus Paclitaxel-eluting stent implantation in patients with diabetes mellitus.
    J Am Coll Cardiol, 52(9): 727-33. [Abstract] [Full-text]
56. Differences in body composition and cardiovascular and type 2 diabetes risk factors between migrant and British-born British Pakistani women.
    Am J Hum Biol, 20(5): 545-9. [Abstract] [Full-text]
57. 17beta-Estradiol and/or progesterone protect from insulin resistance in STZ-induced diabetic rats.
    J Steroid Biochem Mol Biol, 111(3): 287-94. [Abstract] [Full-text]
58. Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.
    J Steroid Biochem Mol Biol, 111(3): 262-7. [Abstract] [Full-text]
59. Independent associations between low-density lipoprotein cholesterol and cancer among patients with type 2 diabetes mellitus.
    CMAJ, 179(5): 427-37. [Abstract] [Full-text]
60. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options.
    Am J Med, 121(9): 748-57. [Abstract] [Full-text]
61. The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy.
    Lab Invest, 88(9): 949-61. [Abstract] [Full-text]
62. The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis.
    Am J Kidney Dis, 52(3): 454-63. [Abstract] [Full-text]
63. Care of vision and ocular health in diabetic members of a national diabetes organization: a cross-sectional study.
    BMC Health Serv Res, 8: 159. [Abstract] [Full-text]
64. Ultrastructure of islet microcirculation, pericytes and the islet exocrine interface in the HIP rat model of diabetes.
    Exp Biol Med (Maywood), 233(9): 1109-23. [Abstract] [Full-text]
65. Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy.
    J Am Soc Nephrol, 19(9): 1701-11. [Abstract] [Full-text]
66. IHG-1 amplifies TGF-beta1 signaling and is increased in renal fibrosis.
    J Am Soc Nephrol, 19(9): 1672-80. [Abstract] [Full-text]
67. Exclusion of polymorphisms in carnosinase genes (CNDP1 and CNDP2) as a cause of diabetic nephropathy in type 1 diabetes: results of large case-control and follow-up studies.
    Diabetes, 57(9): 2547-51. [Abstract] [Full-text]
68. Exploration of the utility of ancestry informative markers for genetic association studies of African Americans with type 2 diabetes and end stage renal disease.
    Hum Genet, 124(2): 147-54. [Abstract] [Full-text]
69. Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36.
    Diabetes, 57(9): 2321-31. [Abstract] [Full-text]
70. Reduction of Ptf1a gene dosage causes pancreatic hypoplasia and diabetes in mice.
    Diabetes, 57(9): 2421-31. [Abstract] [Full-text]
71. Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation.
    Diabetes, 57(9): 2445-52. [Abstract] [Full-text]
72. Plasmacytoid precursor dendritic cells from NOD mice exhibit impaired function: are they a component of diabetes pathogenesis?
    Diabetes, 57(9): 2360-70. [Abstract] [Full-text]
73. Association testing of novel type 2 diabetes risk alleles in the JAZF1, CDC123/CAMK1D, TSPAN8, THADA, ADAMTS9, and NOTCH2 loci with insulin release, insulin sensitivity, and obesity in a population-based sample of 4,516 glucose-tolerant middle-aged Danes.
    Diabetes, 57(9): 2534-40. [Abstract] [Full-text]
74. Pericyte migration: a novel mechanism of pericyte loss in experimental diabetic retinopathy.
    Diabetes, 57(9): 2495-502. [Abstract] [Full-text]
75. Carbon monoxide and nitric oxide mediate cytoskeletal reorganization in microvascular cells via vasodilator-stimulated phosphoprotein phosphorylation: evidence for blunted responsiveness in diabetes.
    Diabetes, 57(9): 2488-94. [Abstract] [Full-text]
76. High-density single nucleotide polymorphism genome-wide linkage scan for susceptibility genes for diabetic nephropathy in type 1 diabetes: discordant sibpair approach.
    Diabetes, 57(9): 2519-26. [Abstract] [Full-text]
77. Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-cells.
    Diabetes, 57(9): 2341-7. [Abstract] [Full-text]
78. Impact of diabetes susceptibility loci on progression from pre-diabetes to diabetes in at-risk individuals of the diabetes prevention trial-type 1 (DPT-1).
    Diabetes, 57(9): 2348-59. [Abstract] [Full-text]
79. Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program.
    Diabetes, 57(9): 2503-10. [Abstract] [Full-text]
80. Metabolic phenotypes, vascular complications, and premature deaths in a population of 4,197 patients with type 1 diabetes.
    Diabetes, 57(9): 2480-7. [Abstract] [Full-text]
81. Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content.
    Diabetes, 57(9): 2288-95. [Abstract] [Full-text]
82. Is the presence of retinopathy of practical value in defining cases of diabetic nephropathy in genetic association studies? The experience with the ACE insertion/deletion polymorphism in 53 studies comprising 17,791 subjects.
    Diabetes, 57(9): 2541-6. [Abstract] [Full-text]
83. Switching-on survival and repair response programs in islet transplants by bone marrow-derived vasculogenic cells.
    Diabetes, 57(9): 2402-12. [Abstract] [Full-text]
84. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.
    Diabetes, 57(9): 2461-9. [Abstract] [Full-text]
85. CHOP T/C and C/T haplotypes contribute to early-onset type 2 diabetes in Italians.
    J Cell Physiol, 217(2): 291-5. [Abstract] [Full-text]
86. Age-dependent impairment of HIF-1alpha expression in diabetic mice: Correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells.
    J Cell Physiol, 217(2): 319-27. [Abstract] [Full-text]
87. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.
    J Am Coll Cardiol, 52(10): 869-81. [Abstract] [Full-text]
88. A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes.
    FASEB J, 22(9): 3310-7. [Abstract] [Full-text]

© 2004-2008 Diabetes Research Today. All Rights Reserved.